<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0004808'>Acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) or <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) is observed in 5 to 10% of patients treated with high-dose chemotherapies followed by autologous stem cell and bone marrow transplantation </plain></SENT>
<SENT sid="1" pm="."><plain>Both diseases are frequently associated with <z:mp ids='MP_0004026'>monosomy</z:mp> 7 (-7), <z:mp ids='MP_0004027'>trisomy</z:mp> 8 (+8), loss of the long arm of chromosome 5 (-5q), and deletions including the TP53-gene region according to del(17)(p13) </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we examined whether these chromosomal aberrations are already detectable in blood stem cells from patients who have <z:hpo ids='HP_0000001'>all</z:hpo> been treated with standard chemotherapies prior to peripheral blood stem cell transplantation (PBSCT) </plain></SENT>
<SENT sid="3" pm="."><plain>Therefore, we screened peripheral blood derived stem cells obtained at the time of stem cell harvest for the presence of -7, +8, -5q, and del(17)(p13) by fluorescence in situ hybridization (FISH) </plain></SENT>
<SENT sid="4" pm="."><plain>Our series included 40 patients: 4 patients with <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e>, 6 patients with non-Hodgkin-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL), 1 patient with ALL, 4 patients with <z:e sem="disease" ids="C0032131" disease_type="Neoplastic Process" abbrv="">plasmocytoma</z:e>, and 25 patients with <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Peripheral blood mononuclear cells (PBMC) from eight healthy blood donors served as controls </plain></SENT>
<SENT sid="6" pm="."><plain>Assuming a hybridization efficiency of &gt;98%, the cut-off level of non diploid cells was determined for each DNA-probe </plain></SENT>
<SENT sid="7" pm="."><plain>None of the stem cell preparations exhibited chromosomal damage </plain></SENT>
<SENT sid="8" pm="."><plain>Our findings indicate that chromosomal damage is a rare event in stem cell autografts </plain></SENT>
</text></document>